Dr. Harrison Kim, PhD
Claim this profileUniversity of Alabama at Birmingham
Studies Pancreatic Cancer
Studies Glioblastoma
3 reported clinical trials
3 drugs studied
Area of expertise
1Pancreatic Cancer
Stage I
Stage II
Stage III
2Glioblastoma
Affiliated Hospitals
Clinical Trials Harrison Kim, PhD is currently running
P4 Diagnostic Tool
for Pancreatic Cancer
The goal of this study is to investigate whether the therapeutic response of pancreatic tumors can be accurately assessed using quantitative DCE-MRI, when the inter/intra-scanner variability is reduced using the Point-of-care Portable Perfusion Phantom, P4. The intra-scanner variability over time leads to errors in therapy monitoring, while the inter-scanner variability impedes the comparison of data among institutes. The P4 is small enough to be imaged concurrently in the bore of a standard MRI scanner with a patient for real-time quality assurance. The P4 is safe, inexpensive and easily operable, thus it has great potential for widespread and routine clinical use for accurate diagnosis, prognosis and therapy monitoring. This study has identified two arms, one arm is healthy individuals that will undergo DCE MRI at three different MRI locations to establish baseline results. The healthy volunteers will undergo these MRIs prior to the second arm, which contains patients with pancreatic cancer. The pancreatic cancer patients will only have DCE MRI done at one location.
Recruiting1 award N/A3 criteria
Imaging-Guided Chemotherapy
for Pancreatic Cancer
The goal of this study is to test whether chemotherapy guided by a new imaging method named DCE-MRI can more effectively reduce a pancreatic tumor, enabling curable surgery, over the conventional method when a tumor is categorized as borderline resectable pancreatic cancer. UAB radiological research team has been studying a cutting-edge imaging technique named dynamic contrast-enhanced magnetic resonance imaging, or DCE-MRI, for over 10 years. This technique has been globally used to calculate the blood flow of various tissues, including tumors. Blood flow often serves as a critical indicator showing a disease status. For example, a pancreatic tumor typically has low blood flow, so it can be used as an indicator to identify the presence of a pancreatic tumor. In addition, an effective therapy can result in the increase of blood flow in a pancreatic tumor during the early period of treatment. Therefore, the investigators may be able to determine whether the undergoing therapy is effective or not by measuring the change of blood flow in the pancreatic tumor and deciding whether to continue the therapy or try a different one.
Recruiting1 award N/A
More about Harrison Kim, PhD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Harrison Kim, PhD has experience with
- Neoadjuvant Chemotherapy
- Point-of-care Portable Perfusion Phantom (P4)
- Point-of-care Portable Perfusion Phantom, P4
Breakdown of trials Harrison Kim, PhD has run
Pancreatic Cancer
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Harrison Kim, PhD specialize in?
Harrison Kim, PhD focuses on Pancreatic Cancer and Glioblastoma. In particular, much of their work with Pancreatic Cancer has involved Stage I patients, or patients who are Stage II.
Is Harrison Kim, PhD currently recruiting for clinical trials?
Yes, Harrison Kim, PhD is currently recruiting for 2 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Harrison Kim, PhD has studied deeply?
Yes, Harrison Kim, PhD has studied treatments such as Neoadjuvant Chemotherapy, Point-of-care Portable Perfusion Phantom (P4), Point-of-care Portable Perfusion Phantom, P4.
What is the best way to schedule an appointment with Harrison Kim, PhD?
Apply for one of the trials that Harrison Kim, PhD is conducting.
What is the office address of Harrison Kim, PhD?
The office of Harrison Kim, PhD is located at: University of Alabama at Birmingham, Birmingham, Alabama 35294 United States. This is the address for their practice at the University of Alabama at Birmingham.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.